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Abstract
Background: Osteochondral defects continue to be a clinical treatment challenge, and when left untreated, may
cause pain and functional impairment. Pyrolytic carbon is a unique isotropic biomaterial used in heart valve and
small joint replacements due to its excellent wear properties and biocompatibility with bone and articular cartilage.
Therefore, a proposed solution is to utilize a focal pyrolytic carbon hemiarthroplasty implant as an alternative
resurfacing treatment strategy for isolated cartilage lesions.
Methods: A canine model (n = 9) was used to evaluate the in vivo histologic response and function of a pyrolytic
carbon implant replacing a full-thickness osteochondral defect in the medial femoral condyle (MFC) of the knee.
The gross appearance and histologic results were compared to an identical cobalt-chromium (Co-Cr) alloy implant
placed in a defect in the contralateral MFC and evaluated up to 52 weeks.
Results: Extensive bone incorporation to the stem portion was observed for both implant types. The total mean
histologic score for the cartilage of the MFC surrounding the pyrolytic carbon implants was significantly improved
compared to that of the Co-Cr alloy implants at all evaluation periods (p < 0.05). Histologic grading and gross
observations at 52 weeks for pyrolytic carbon implants were similar to those of Co-Cr alloy implants at 24 weeks.
At 24 weeks, the mean total histologic score for Co-Cr alloy implants was 11.6 ± 0.7 (0–16 range point; 16 = normal
appearance), while at 52 weeks, the mean total score for the pyrolytic carbon implants was 11.7 ± 1.3. Mean total
histologic score of opposing medial tibia cartilage for the pyrolytic carbon implants was superior to that of the
Co-Cr alloy group at all evaluation periods and significantly improved over the Co-Cr alloy implant group at
24 weeks (p = 0.001) and 52 weeks (p < 0.001).
Conclusions: Use of a pyrolytic carbon implant for reconstruction of a focal cartilage defect demonstrated effective
implant fixation and superior in vivo response compared to an identical Co-Cr alloy implant.
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Background
Osteochondral defects of the medial femoral condyle
negatively impact functionality of the knee. Symptomatic
lesions are generally painful and disabling, and can
progress to osteoarthritis when left untreated. Not only
is the repair tissue in a focal chondral or osteochondral
defect inferior to normal articular cartilage but the pres-
ence of defects can also damage the opposing meniscus
and tibial cartilage surface [1, 2].
Currently, there are several treatments available, which
depending on the goal of the intervention, may be
directed at relieving symptoms, regenerating tissue, or
repairing the defect. Arthroscopic debridement and
lavage alleviate symptoms but the long-term result for
the lesion is poor [1, 3–6]. Abrasion chondroplasty, sub-
chondral drilling, and microfracture have been shown to
regenerate tissue with acceptable results, but the result-
ing fibrocartilage lacks the strength, organization, and
biomechanics of normal articular cartilage [1, 7, 8].
Autologous chondrocyte implantation has produced good
to excellent outcomes, but the multi-step procedure in-
volves extensive rehabilitation, may not be appropriate for
older or heavier patients, and also carries a risk of donor
site morbidity [1, 9, 10]. In severe cases of osteoarthritis or
in cases where other regenerative or revision techniques
have failed, a total knee arthroplasty (TKA) is the most ef-
fective solution. However, total knee arthroplasty is a final
resort for many patients due to likelihood of revision sur-
geries (usually within 15–20 years) and associated morbid-
ity throughout the patient’s lifetime. For younger patients
with TKAs, revision surgeries are more likely due to in-
creased activity of younger patients which leads to greater
implant wear and reduced implant lifespan [11–14].
A proposed solution is a focal hemiarthroplasty implant,
intended for use as an alternative resurfacing treatment
strategy for isolated lesions in patients who are too young
for TKAs [1] or not good candidates for regenerative pro-
cedures. Focal hemiarthroplasty devices using pyrolytic
carbon [15], metal alloys [15, 16], polymer composites
[17], and ceramic composites [18] have been investigated
for a number of anatomical locations with varying results.
Several previous studies have shown that even when the
shape and design of the implant closely match the surface,
the implant material properties may be detrimental to the
opposing articular cartilage in the long-term due to
differences in elastic modulus [15, 19, 20]. A mismatch in
elastic properties contributes to higher stresses around the
implant-bone interface, which leads to bone loss due to
stress shielding, followed by bone resorption and implant
loosening [21, 22].
Wear of articulating surfaces can also be a major limiting
factor in arthroplasty and hemiarthroplasty. In the natural
joint, surface-active phospholipids (SAPL) and their major
component, dipalmitoylphosphatidylcholine (DPPC), have
been found to possess remarkable capabilities in reducing
friction and are excellent anti-wear agents even under high
loads [23, 24]. Thus, researchers have identified that SAPL
acts as the active boundary lubricant in both natural and
artificial joints. A deficiency in SAPL, as in osteoarthritis,
results in sticking of the articulating surfaces [25]. Purbach
et al. [26] was the first to report on the presence of SAPL
on artificial joints. Analysis of total hip replacement
prostheses showed that sufficient SAPL was present
to form oligolamellar layers on the bearing surfaces,
suggesting that this layered structure of phospholipids
acts similar to lamellated solid lubricants and protects
the surface from wear.
Pyrolytic carbon has been shown to have superior
qualities for use in partial and total joint replacements
due, in part, to its similar elastic modulus to bone, which
reduces stress shielding [27]. Pyrolytic carbon also has
high strength, high fatigue resistance, and high wear
resistance even when subjected to cyclic loads [28–30].
Pyrolytic carbon has been shown to be biocompatible
with both hard and soft tissues, which is important for
minimizing host inflammatory response to an implanted
medical device [29, 31–33]. Studies have also shown that
DPPC has a high affinity for pyrolytic carbon, indicating
that SAPL will likely do the same [34, 35], thus effectively
lubricating and reducing the friction between cartilage
articulating against a pyrolytic carbon implant surface.
Experimental studies have been conducted using pyro-
lytic carbon as a hemiarthroplasty material. Cook et al.
[28] evaluated degeneration of acetabular cartilage
following implantation of proximal femoral hemiarthro-
plasties in dogs. The articulating surface of the femoral
component was composed of either pyrolytic carbon,
cobalt-chromium-molybdenum (Co-Cr-Mo) alloy, or
titanium alloy. Results indicated that native acetabulum
in articulation with pyrolytic carbon implants experi-
enced a lesser degree of joint degeneration and there
was significantly greater probability of cartilage survival
with articulation against the pyrolytic carbon implant
compared to the metal alloy implants. In an ost-
eoarthritis model, Kawalec et al. [15] examined the
histologic response to pyrolytic carbon and cobalt-
chromium (Co-Cr) alloy hemiarthroplasty implants in
the lateral femoral condyle of the knee in beagle dogs
compared to an untreated cartilage control group. To
simulate degeneration and loss of cartilage associated
with osteoarthritis, Kawalec et al. created an osteochon-
dral defect on the opposing lateral surface of the tibial
plateau that articulated with a pyrolytic carbon device, a
similar Co-Cr device, or the native condyle cartilage. Re-
sults showed no evidence of adverse inflammatory re-
sponse, and fibrocartilage regeneration in 86% of knees
treated with the carbon implants but only in 25% of
metal implants. Improved fibrocartilage regeneration
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was attributed to the more “normal” biomechanical con-
dition of the bone-carbon articulation than the bone-
metal articulation.
The objective of this study was to use a canine model
to evaluate the in vivo histologic response and function
of a pyrolytic carbon implant in the medial femoral
condyle of the knee and to compare the results to those
obtained using an identical Co-Cr alloy implant.
Methods
Test devices
The device used in this study was a weight-bearing,
cementless, single-component articular implant fabri-
cated from either pyrolytic carbon or Co-Cr alloy and
designed for implantation in the medial femoral condyle
of the study animals (Fig. 1). The devices had an articu-
lating surface with a 6-mm diameter and 11-mm radius
of curvature. The stem was tapered with a series of four
grooves, and the total height of the device was 12.35 mm.
The pyrolytic carbon implants were machined from
graphite with a pyrolytic carbon coating applied in a fluid-
ized bed reactor. The implant’s stem surface had the as-
deposited pyrolytic carbon material, while the articulating
surfaces were polished to less than 2 μin. The articulating
surfaces of the Co-Cr alloy implants were also polished to
less than 2 μin. and the stem portion had a grit-blasted
surface. The choice of a Co-Cr alloy analogous implant to
the pyrocarbon implant was made based on currently
available similarly functioning clinical implants such as
the Co-Cr alloy HemiCAP device (Arthrosurface Inc.,
Franklin, MA) and the characterization of Co-Cr as a con-
trol articular implant in the literature in this application
[15, 16] and in a similar articular joint application [28].
Experimental design
Nine adult male beagle dogs, 1.6 ± 0.1 years of age, were
used in the study (12.8 ± 2.2 kg). The study was under-
taken after receiving approval from the In-Life Facility’s
IACUC committee for all animal care and procedures.
The animals were assigned to the following evaluation
periods: 12 weeks post-surgery (n = 3), 24 weeks post-
surgery (n = 3), and 52 weeks post-surgery (n = 3).
Surgical procedure and radiographic evaluation
All animals underwent bilateral implantation of the de-
vices in the medial femoral condyle (pyrolytic carbon in
one knee and Co-Cr alloy in the other, Fig. 2). Under ster-
ile conditions, the medial capsule of the knee joint was
approached through a median parapatellar incision. The
medial retinaculum was partially released to dislocate the
patella and the knee flexed to expose the medial femoral
condyle. After exposure, a tapered defect representative of
a grade IV cartilage lesion was produced using a series of
custom guides and drills. The implant was then seated
into the surgically created osteochondral defect site, using
custom insertion instruments to ensure device alignment
and surface continuity of the implant and articular surface.
Anterior-posterior (AP) and lateral radiographs of the
joint were taken immediately before and after surgery and
at 6, 12, 24, and 52 weeks postoperative. Animals received
tramadol (Ultram, 25 mg/dog, BID, oral) from day 1 to 5
(day 0 = surgical day) for management of postoperative
pain. Animals received buprenorphine (0.01 mg/kg, intra-
muscular or subcutaneous (SC)) as deemed appropriate
by the attending veterinarian to control moderate to se-
vere pain. Acepromazine (0.2 mg/kg, SC) was adminis-
tered as needed to minimize distress and improve
anesthetic recovery.
Lameness evaluation
A single, blinded observer recorded the extent of lame-
ness to each knee joint using a numerical grading scale
modified from Paradis et al. [36]. A lameness score of 0
was given if the animal could stand, walk, and trot nor-
mally; 1, if they stood normally and had a slight algetic
gait; 2, if they stood abnormally and had a slight algetic
gait; 3, if they stood normally and had an evident algetic
gait; and 4, if they stood abnormally and had an evident
algetic gait. Evaluations were performed once every
3 days during the first three postoperative weeks and
then once at each radiograph interval (6, 12, 24, and
52 weeks postoperative).
Gross necropsy
Immediately following sacrifice, knee joints were har-
vested and contact radiographs taken. Harvested joints
were grossly assessed for observations of the articular
surfaces and surrounding cartilage, meniscus, and
synovial joint tissues, as well as any discoloration or
degenerative changes of the surrounding cartilage and
discoloration of the synovial fluid.
Fig. 1 Pyrolytic carbon (left) and Co-Cr alloy (right) implant devices
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Histology of medial femoral condyle cartilage and
observation of bone-implant interface
Following gross evaluation, specimens for histology were
fixed in 10% formalin and dehydrated in graduated ethyl
alcohol solutions. Specimens were then embedded in
methyl methacrylate monomer, allowed to polymerize,
and sectioned in the sagittal plane central to the
implant’s long axis. Three centermost ground sections
relative to the condyles were obtained, mounted, and
ground/polished to approximately 50 μm thick. Sections
were stained with Paragon. Microradiographs of the final
sections were made using high-resolution Faxitron film
(Industrex, Carestream). Undecalcified histologic sections
were assessed using a semi-quantitative grading scale
(Table 1), adapted from histologic assessments made by
Kirker-Head et al. [16]. The percentages of bone contact,
soft tissue contact, and void space contact with the im-
plant were measured via digital images taken at ×2 (Nikon
DXM1200) and image analysis software (Image-Pro Plus,
Media Cybernetics).
Tibial articular cartilage evaluation
Medial and lateral tibial plateaus with intact menisci
were collected and processed using decalcified paraffin-
embedded techniques. Each specimen was sectioned into
medial, central, and lateral blocks. From each block,
three serial sections (5 μm thick) were obtained and
stained with H&E, toluidine blue, and safranin O/fast
green. Medial sections were examined using a modified
ICRS-Histological Visual Scale [37], which was modified
to reflect changes to existing hyaline cartilage by the
presence of an articulating implant (Table 2). Lateral
sections were observed as comparative controls for
cartilage and staining.
Statistical methods
The pyrolytic carbon and Co-Cr alloy devices were
evaluated as pair-wise, within-animal comparisons.
Descriptive statistics of histologic data were calculated. All
quantitative data were initially screened for statistical out-
liers, defined as data points with z-scores of 3.0 or greater.
Analysis of variance (ANOVA) was used to determine the
effect of the experimental group (pyrolytic carbon and
Co-Cr alloy) and postoperative time (12, 24, and 52 weeks).
Non-parametric ANOVA was used to determine the effect
of the experimental group and postoperative time on the
histologic scores (Kruskal-Wallis test [38]). Significance (*)
was defined as p ≤ 0.05. Data are presented as mean ±
standard deviation.
Fig. 2 Inter-operative photograph of placement of pyrolytic carbon (a) and Co-Cr (b) implants in the medial condyle
Table 1 Histology grading scale (modified from Kirker-Head et al.
[16]) used in evaluation of medial femoral condyle cartilage
Feature Score
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Results
Surgical procedure, lameness evaluation, and
radiographic evaluation
All animals tolerated the procedures well, had uneventful
recoveries, and remained in good health until time of
sacrifice. Within 4 weeks postoperative, all animals were
ambulatory without evidence of lameness or impairment,
and had normal stance bilaterally without evidence of
non-weight bearing or pain during walking. Lameness
scores did not exceed a grade of 2 (generally noted bilat-
erally), and evidence of slight lameness did not persist
beyond week 3. One animal had three occurrences of right
hindlimb lameness (Co-Cr alloy implant) at 14, 17, and
25 days postoperative, in which the contralateral hindlimb
(pyrolytic carbon implant) was normal.
Review of postoperative radiographs showed adequate
placement of all implants (Fig. 3). There was no radio-
graphic evidence of loosening of the implants during the
course of this study. Radiolucency around the pyrolytic
carbon implant was the result of the radiolucent pyro-
lytic carbon coating thickness, and this was accounted
for in the observations.
Gross necropsy
At 12 weeks, gross observations (Fig. 4) of the pyrolytic
carbon implanted knees showed no evidence of articular
cartilage damage or color change; no joint capsule hyper-
trophy, osteophyte formation, or meniscal changes related
to the implant; and normal appearance of the synovial
fluid. Gross observations of the Co-Cr alloy implanted
knees showed no evidence of articular cartilage damage,
one instance of opaque articular cartilage, two instances of
joint capsule hypertrophy, one instance of osteophyte for-
mation, and one instance of mild degeneration/streaking
and thin, translucent appearance of the medial meniscus.
At 24 weeks, observation of the pyrolytic carbon im-
planted knees revealed one knee with moderate degener-
ation of the cartilage and minimal changes to the medial
tibial plateau. For the Co-Cr alloy implanted knees, two
had minimal fibrillation/degeneration of the cartilage on
both the medial femoral condyle and medial tibial plat-
eau surfaces, one with slight opacity changes in the ar-
ticular cartilage, one with a thickened joint capsule, one
osteophyte presence, one medial meniscus with mild de-
generation/streaking, and no finding related to the gross
appearance of the ligaments.
At 52 weeks, two of the pyrolytic carbon implanted
knees had moderate degenerative changes of the cartilage
on the medial femoral condyle with no changes on the
medial tibial plateau surfaces and both had slight opacity
changes to the articular cartilage. An osteophyte was
present on one knee with mild streaking on the rim of one
medial meniscus. All ligaments appeared normal. For the
Co-Cr alloy implanted knees, one knee had moderate fib-
rillation/degeneration of the cartilage on both the medial
femoral condyle and the medial tibial plateau surfaces and
the articular cartilage was discolored. One knee had a
thickened joint capsule with hypertrophy of the lateral col-
lateral ligaments, two knees had condylar osteophytes, and
one knee had a medial meniscus with evidence of moder-
ate degeneration and a thinned, translucent appearance.
Histology of medial femoral condyle cartilage and
observation of bone-implant interface
Histologic grading of the medial femoral condyle tissues
showed that no significant inflammatory response was
Table 2 Histology grading scale (modified from Mainil-Varlet et al.
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observed to either implant material at any evaluation
period. The scores for the amount of cartilage flow over
the implant (Fig. 5a) and the degree of implant-bone
apposition (Fig. 5b) showed no significant differences
between the two groups at any time point (Fig. 6). The
mean implant-cartilage interface score for the pyrolytic
carbon group was significantly improved compared to
that of the Co-Cr alloy group at all time points (p < 0.05)
(Fig. 5c). Histologic sections at 52 weeks postoperative
demonstrated excellent maintenance of the host
cartilage-implant interface with minimal cellular and
mechanical changes present for the pyrolytic carbon
implant, while significant cellular changes with loss of
matrix staining was observed for the Co-Cr alloy im-
plant at and near the host cartilage-implant interface
(Fig. 7). The mean cartilage morphology score for the
pyrolytic carbon group was significantly improved com-
pared to that of the Co-Cr alloy group at 24 and
52 weeks (Fig. 5d). Overall, the mean total score of the
pyrolytic carbon group was significantly improved over
that of the Co-Cr alloy group at all evaluation periods
(p < 0.05) (Fig. 8). Histologic grading and observations at
52 weeks for pyrolytic carbon implants were similar to
those of Co-Cr alloy implants at 24 weeks. At 24 weeks,
Fig. 3 Postoperative radiographs: pyrolytic carbon (top) and Co-Cr (bottom) implants at 12 weeks (a, d), 24 weeks (b, e), and 52 weeks (c, f)
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the mean total score for Co-Cr alloy implants was
11.6 ± 0.7, while at 52 weeks, the mean total score for
the pyrolytic carbon implants was 11.7 ± 1.3.
There were no significant differences (paired t test,
p > 0.05) observed between the two test groups regarding
the quantitative measurements of mean percent bone con-
tact (p = 0.617), percent soft tissue contact (p = 0.470), and
percent void space at the implant interface (p = 0.964)
(Table 3).
Tibial articular cartilage evaluation
Overall, the pyrolytic carbon implant group had superior
histologic appearances for the medial tibia articulating
surface over that of the Co-Cr alloy implant group at all
evaluation periods (Fig. 9). In most pyrolytic carbon
sections, the cartilage surface appeared normal with
minimal mechanical damage or cellular changes. Isolated
areas of cell clusters with early mechanical changes were
observed in limited sections (Fig. 9, top right). Loss of
matrix staining was observed for most Co-Cr alloy
sections with cellular changes present, as well as mech-
anical damage at the cartilage surface (Fig. 9, bottom
right). There was no significant difference in scores at
12 weeks; however, mean total histologic scores of the
tibial articular cartilage were significantly improved at
24 weeks (p = 0.001) and 52 weeks (p < 0.001) for the
pyrolytic carbon implant group (Fig. 10). Regarding
within-animal paired comparison at 52 weeks, pyrolytic
carbon was superior to Co-Cr alloy in all subcategories
(p < 0.05). In eight of nine paired comparisons, the over-
all histologic score of the tibial surface was superior for
the pyrolytic carbon implant side than the Co-Cr alloy
Fig. 4 Gross appearance of pyrolytic carbon (left) and Co-Cr alloy (right) implants at 12 weeks (a, b), 24 weeks (c, d), and 52 weeks (e, f)
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Fig. 5 MFC histologic scores, means. a Cartilage flow over implant. b Implant-bone apposition. c Implant-cartilage interface. d Cartilage
morphology. *p < 0.05
Fig. 6 52-week histologic sections: microradiographs of pyrolytic carbon (top) and Co-Cr alloy (bottom) implants. Note radiolucent pyrolytic carbon
coating surrounding radio-dense substrate (×2)
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side, with no statistically significant difference in the
remaining comparison pair.
At 12 weeks, changes were primarily observed in the
cellular morphology of the tibial cartilage, while structural
changes were noted at both 12 and 52 weeks. Occasional
loss of columnar orientation with cell clusters and loss of
cell viability were observed at 12 weeks, as well as some
loss of matrix GAG staining. At 24 weeks, cartilage
surface changes were first observed with moderate irregu-
larities, particularly for the Co-Cr alloy implants. Degen-
erative changes occurred to a lesser extent in the pyrolytic
carbon group. Histologic scores decreased significantly
from 12 to 24 weeks for both implant materials, with a
greater decrease for the Co-Cr alloy group from 20.3 ± 2.3
to 16.2 ± 2.8 (p < 0.0001) than for the pyrolytic carbon
group which decreased from 21.3 ± 1.9 to 19.0 ± 2.4
(p = 0.0005). Mean total histologic scores stabilized at
52 weeks compared to the earlier evaluation periods.
The mean total histologic score of the pyrolytic car-
bon implants was significantly improved compared to
that of the Co-Cr alloy specimens (p < 0.001) with
mean total histologic scores of 21.9 ± 1.0 and 16.7 ±
4.3, respectively. Histologic appearances of the tibial
cartilage and meniscus at 52 weeks were similar to
those at 24 weeks for each respective implant
material.
Discussion
This study demonstrated that a pyrolytic carbon hemiar-
throplasty implant material was superior to identical
Co-Cr alloy implants. Less cartilage degeneration was
observed in the cartilage adjacent to and in the vicinity of
the pyrolytic carbon implants compared to the Co-Cr
alloy implants in the medial femoral condyle at all evalu-
ation periods. Surface cartilage wear, degradation, and
cellular change were reduced when articulating against
the pyrolytic carbon implants. In particular, changes in the
tibial cartilage observed for the pyrolytic carbon group at
52 weeks were seen as early as 12 weeks for the Co-Cr
alloy group. Both implant groups achieved a similar
degree of direct bone-implant apposition at 12, 24, and
52 weeks.
The concept of a minimally invasive hemiarthroplasty
for the treatment of focal osteochondral knee defects of-
fers the advantages of reduced pain, a shorter hospital
stay, and increased range of motion. Hemiarthroplasty
also preserves bone stock, allowing for future revision or
total joint replacement, if needed. While most devices
require replacement of the opposing tibial articular sur-
face, the device in this study does not and is comparable
in concept to the current marketed device that requires
resurfacing of only one articular surface—the HemiCAP
(Arthrosurface Inc., Franklin, MA).
Fig. 7 52-week sections of a pyrolytic carbon (left) and Co-Cr alloy (right) implant. Toluidine blue, basic fuchsin, magnification: ×2
Fig. 8 Mean total histologic scores for MFC cartilage. Significance,
p < 0.05*
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p value (paired t test) 0.617 0.470 0.964
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The HemiCAP consists of a bone fixation element and
an articular component connected by a Morse taper.
The bearing surface is Co-Cr-Mo alloy with titanium
plasma spray on the underside for bone ongrowth. The
biological and functional response of the HemiCAP was
investigated in goats [16]. Radiologically, there was no
evidence of implant failure or loosening nor any gross
degenerative changes. Histological analysis showed new
trabecular bone abutting the implant in all specimens at
1 year postoperatively. The medial femoral condyle
cartilage lateral to the implant was fibrocartilage-like,
whereas it was hyaline cartilage-like medial to the
implant [16]. Histologic examination of the proximal
tibia cartilage surface opposing the HemiCAP implant
was characterized by the presence of fibrillations, similar
to those observed in this study for the Co-Cr alloy
group. Given its high fatigue and high wear resistance,
biocompatibility, reduced elastic modulus, and propensity
for SAPL adhesion to form a boundary lubricant, pyrolytic
carbon offers the potential for improved clinical perform-
ance of implants for this partial joint resurfacing applica-
tion compared to Co-Cr alloy.
One of the limitations of the surgical model used is
that the implants were placed in a joint that was not
truly arthritic. The implants were placed in a joint at the
same time that the defect was made. This study also did
not include control groups with osteochondral defects
that were left untreated or, as previously stated, defects
that were left untreated for a substantial period of time
prior to implantation. It is important to note that it has
been shown that untreated osteochondral defects result
in deterioration of both the adjacent cartilage and the
opposing cartilage on which it articulates [15].
In a study comparing the results of untreated critical-
size cartilage defects in the medial femoral condyle of
goats with defects treated with oxidized zirconium or Co-
Cr small hemiarthroplasty implants after 52 weeks, 13 of
16 analyzed implants showed good osseointegration and
high bone-implant contact (40–60%) [39]. Previous rabbit
studies showed similar bone-implant contact percentages,
ranging from 36 ± 4% [40] to 47.5 ± 4.7% [41]. The present
study had comparable bone-implant contact with a mean
of 34.5 ± 15.9% for the Co-Cr alloy implants and 30.2 ±
20.4% for the pyrolytic carbon implants.
Although fibrillation was rarely seen by Custers et al.
[39], a previous study involving fixation of pyrolytic carbon
and titanium implants in mongrel dogs showed moderate
fibrillation of the opposing cartilage surface by the pyrolytic
carbon implant and severe fibrillation by the titanium
Fig. 9 Tibia cartilage surfaces articulating against pyrolytic carbon (top) and Co-Cr (bottom), 52 weeks. ×2 (left), ×10 (right)
Fig. 10 Mean total histologic scores for the medial menisco-tibial
surface. *Significance, p < 0.05
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device at 12 months [42]. In the present study, no changes
on the medial tibia plateau surface opposing the pyrolytic
carbon implant were observed, but moderate fibrillation of
the opposing tibia cartilage surface was observed for one of
the three knees treated with Co-Cr alloy implants at
52 weeks. In another study by Cook et al. [28] using hip
endoprosthesis in a canine model, areas of wear were much
less extensive in animals with pyrolytic carbon devices, and
there was significantly less fibrillation of opposing cartilage
seen with the pyrolytic carbon implants compared to both
Ti-6Al-4V and Co-Cr-Mo alloy devices (all p < 0.0075).
Based on the direct comparison of pyrolytic carbon to
identical metal alloy implants, it is hypothesized that the
improved performance of pyrolytic carbon devices results
from reduced material elastic modulus, as well as lower
surface energy and the non-adhesive nature of the pyrolytic
carbon surface [43]. In addition, the high affinity of SAPL
to the surface of pyrolytic carbon assists in the formation
of a boundary lubricant for reduced wear and friction
during articulation [34, 35] which could contribute to the
improved outcomes on the opposing cartilage surface.
Another limitation to this study is the small number
of animals, which may skew statistical elements. How-
ever, bilateral surgery allows for intra-animal pair-wise
comparison and therefore a reduced number of animals
needed for the study. It also allows a direct comparison
of the two implant materials. Studies performed in a
larger sheep model comparing pyrolytic carbon implants
to a chondroplasty control group are underway.
Conclusions
In summary, the use of pyrolytic carbon as a hemiar-
throplasty implant material was shown to be superior to
Co-Cr alloy, which is the material that is currently being
used in a marketed clinically available hemiarthroplasty
knee device. Less degeneration was observed in the
cartilage adjacent to and in the vicinity of the pyrolytic
carbon implants compared to the Co-Cr alloy implants
in the medial femoral condyle at all evaluation periods
out to 1 year. There was also less wear, degradation, and
cellular changes of the tibial cartilage surface when
articulating against the pyrolytic carbon implants.
Changes in the tibial cartilage observed for the pyrolytic
carbon group at 52 weeks were seen as early as 12 weeks
for the Co-Cr alloy group. Again, larger sheep models
comparing a clinical pyrolytic carbon device to control
chondroplasty-treated defects are underway.
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